Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.2551
0.00 (0.00%)
Aug 10, 2026, 4:00 PM EST
Avenue Therapeutics Employees
Avenue Therapeutics had 1 employees as of December 31, 2025. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,777,000
Market Cap
840.55K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1 | -1 | -50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | -2 | -50.00% |
| Dec 31, 2021 | 4 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Emmaus Life Sciences | 33 |
| Evofem Biosciences | 29 |
| Lyra Therapeutics | 27 |
| NKGen Biotech | 26 |
| CERo Therapeutics Holdings | 8 |
| AXIM Biotechnologies | 7 |
| ZyVersa Therapeutics | 6 |
Avenue Therapeutics News
- 4 days ago - Avenue Therapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - Avenue Therapeutics Quarterly report: Q1 2026 - Filings
- 4 months ago - Avenue Therapeutics Annual report: Q4 2025 - Filings
- 6 months ago - Avenue Therapeutics enters worldwide license agreement for ATX-04 - TheFly
- 8 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 8 months ago - Avenue Therapeutics Proxy statement: Proxy Filing - Filings
- 9 months ago - Avenue Therapeutics Quarterly report: Q3 2025 - Filings
- 9 months ago - Avenue Therapeutics announces Baergic Bio acquisition by Axsome - TheFly